Cargando…
A phase II study of capecitabine and docetaxel combination chemotherapy in patients with advanced gastric cancer
Capecitabine and docetaxel have considerable single-agent activity in gastric cancer with distinct mechanisms of action and no overlap of key toxicities. A synergistic interaction between these two drugs is mediated by taxane-induced upregulation of thymidine phosphorylase. We investigated the activ...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409690/ https://www.ncbi.nlm.nih.gov/pubmed/15054450 http://dx.doi.org/10.1038/sj.bjc.6601724 |